Northwire Canada EditionSunday, July 12, 2026
Northwire
GLDN 0.055 +0.0% BRON 0.040 +0.0% BTO 5.43 −0.7% ESK 0.365 −2.7% AUMN 0.275 +0.0% GGX 0.040 +0.0% S 0.155 +29.2% NNX 0.035 +0.0% ABX 51.90 −0.6% TTS 2.40 −4.0% FCI 0.400 −9.1% GR 0.075 +0.0% AII 23.38 +12.4% TUNG 1.72 +1.8% LGO 1.01 −2.9% EMM 0.080 +0.0% GLDN 0.055 +0.0% BRON 0.040 +0.0% BTO 5.43 −0.7% ESK 0.365 −2.7% AUMN 0.275 +0.0% GGX 0.040 +0.0% S 0.155 +29.2% NNX 0.035 +0.0% ABX 51.90 −0.6% TTS 2.40 −4.0% FCI 0.400 −9.1% GR 0.075 +0.0% AII 23.38 +12.4% TUNG 1.72 +1.8% LGO 1.01 −2.9% EMM 0.080 +0.0%
Earnings

Verano Announces Fourth Quarter and Full Year 2025 Financial Results

VRNO · Price

Executive Summary

  • Verano Holdings reported Q4 2025 revenue of $207 M (‑5% YoY) and full‑year 2025 revenue of $822 M (‑6% YoY), with adjusted EBITDA of $56 M for the quarter and $229 M for the year.
  • The company announced a new $195 M senior secured term loan and an upsized revolving credit facility to $100 M, providing additional liquidity and lower‑cost capital.
  • Operational highlights include expansion to 160 dispensaries in 13 states, redomiciling to Nevada, settlement of Vireo litigation, acquisition of a conditional Texas vertical license, and several new product/partner launches.

Key Details

  • Q4 2025 Financial Highlights
  • Revenue (net of discounts): $207 M (+2% QoQ, ‑5% YoY)
  • Gross profit: $106 M (51% of revenue)
  • SG&A expense: $86 M (42% of revenue)
  • Net loss: $(183) M (‑89% of revenue)
  • Adjusted EBITDA: $56 M (27% of revenue)
  • Cash from operating activities: $14 M
  • Capital expenditures: $9 M

  • Full‑Year 2025 Financial Highlights

  • Revenue (net of discounts): $822 M (‑6% YoY)
  • Gross profit: $413 M (50% of revenue)
  • SG&A expense: $337 M (41% of revenue)
  • Net loss: $(258) M (‑31% of revenue)
  • Adjusted EBITDA: $229 M (28% of revenue)
  • Cash from operating activities: $53 M
  • Capital expenditures: $41 M

  • Liquidity & Financing

  • Closed a $195 M senior secured term loan; drew $50 M under existing revolving facility to retire higher‑cost debt.
  • Revolving credit facility increased to $100 M, maturity extended to 28 Feb 2029; $25 M remains undrawn.
  • As of 31 Dec 2025: cash & equivalents $83 M; total debt (net) $400 M; working capital $264 M.

  • Operational / Strategic Highlights

  • Expanded Ohio footprint to six dispensaries (Zen Leaf Antwerp).
  • Opened Zen Leaf Charleston (6th WV dispensary) and MÜV Deltona (83rd FL dispensary, 160th nationwide).
  • Launched HYPHEN all‑in‑one pod system; introduced Swift Lifts standalone brand.
  • Secured exclusive partnerships with Raw Garden (NJ) and Flower by Edie Parker (FL).
  • Awarded one of nine conditional vertical licenses in Texas, pending final state approval.
  • Redomiciled from British Columbia to Nevada.
  • Settled all litigation with Vireo Growth Inc.

  • Guidance for 2026

  • Expected capital expenditures: $30 M–$50 M, focused on cultivation efficiency, selective retail expansion, store enhancements, and technology/infrastructure investment.

  • Conference Call

  • Scheduled for March 12 2026 at 8:30 a.m. ET; webcast link provided.

Notable Quotes

“I am incredibly proud of our team for their resilience… we are well‑positioned to leverage a number of potential catalysts in what may be a game‑changing year for Verano and the industry in 2026.” – George Archos, Founder, Chairman & CEO.

Read the original news release →

More from VERANO HOLDINGS CORP.